Mometasone (Medium Potency)
Mometasone furoate is a medium-potency topical corticosteroid. It works by activating natural substances in the skin to reduce swelling, redness, and itching. Because of its medium strength, it is effective for moderate skin conditions but must be used with caution, particularly in children, to avoid systemic absorption.
Dosage by Body Weight
Apply a thin film to the affected skin areas once daily. Rub in gently and completely. Do not use with occlusive dressings (bandages, plastic wrap) unless directed by a doctor. Avoid contact with eyes and do not use on the face, underarms, or groin area for extended periods.
- Body Weight
- Below 5 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Infants have a high surface-area-to-body-weight ratio, making them highly susceptible to systemic toxicity, adrenal suppression, and Cushing's syndrome.
- Body Weight
- 5-7 kg
- Dose
- Not routine
- Frequency
- Use only if explicitly prescribed
- Tracking Notes
- Safety and efficacy have not been established in pediatric patients under 2 years of age. Avoid use in diaper area as diapers act as occlusive dressings.
- Body Weight
- 8-10 kg
- Dose
- Apply a very thin film sparingly to affected areas
- Frequency
- Once daily for a maximum of 5 days
- Tracking Notes
- Use the lowest effective amount. Do not apply to large areas or skin folds. Therapy should be discontinued once control is achieved.
- Body Weight
- 11-15 kg
- Dose
- Apply a thin film sparingly to affected areas
- Frequency
- Once daily
- Tracking Notes
- Limit treatment duration to the shortest time possible (usually less than 1-2 weeks). Avoid prolonged continuous use.
- Body Weight
- 16-20 kg
- Dose
- Apply a thin film to affected areas
- Frequency
- Once daily
- Tracking Notes
- Monitor closely for skin thinning (atrophy) or stretch marks. Do not use under occlusive wraps.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not recommended | Do not use | Infants have a high surface-area-to-body-weight ratio, making them highly susceptible to systemic toxicity, adrenal suppression, and Cushing's syndrome. |
| 5-7 kg | Not routine | Use only if explicitly prescribed | Safety and efficacy have not been established in pediatric patients under 2 years of age. Avoid use in diaper area as diapers act as occlusive dressings. |
| 8-10 kg | Apply a very thin film sparingly to affected areas | Once daily for a maximum of 5 days | Use the lowest effective amount. Do not apply to large areas or skin folds. Therapy should be discontinued once control is achieved. |
| 11-15 kg | Apply a thin film sparingly to affected areas | Once daily | Limit treatment duration to the shortest time possible (usually less than 1-2 weeks). Avoid prolonged continuous use. |
| 16-20 kg | Apply a thin film to affected areas | Once daily | Monitor closely for skin thinning (atrophy) or stretch marks. Do not use under occlusive wraps. |
Formulation
Purpose
Relief of the inflammatory and pruritic (itching) manifestations of corticosteroid-responsive dermatoses such as eczema, psoriasis, and allergic dermatitis.
Generic Name
Mometasone furoate 0.1%Branded Drug Names
Mometasone (Medium Potency) is listed as a generic drug name. Common branded medicines that may contain the same active ingredient include:
Scheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.